JP2024507810A5 - - Google Patents
Info
- Publication number
- JP2024507810A5 JP2024507810A5 JP2023549866A JP2023549866A JP2024507810A5 JP 2024507810 A5 JP2024507810 A5 JP 2024507810A5 JP 2023549866 A JP2023549866 A JP 2023549866A JP 2023549866 A JP2023549866 A JP 2023549866A JP 2024507810 A5 JP2024507810 A5 JP 2024507810A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- ovicetrapib
- use according
- ezetimibe
- ldl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NL2021050109 | 2021-02-18 | ||
| NLPCT/NL2021/050109 | 2021-02-18 | ||
| PCT/NL2022/050083 WO2022177428A1 (en) | 2021-02-18 | 2022-02-18 | Combination therapy of obicetrapib and ezetimibe for use in statin intolerant patients suffering from hyperlipidemia or mixed dyslipidaemia |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024507810A JP2024507810A (ja) | 2024-02-21 |
| JP2024507810A5 true JP2024507810A5 (https=) | 2025-02-26 |
Family
ID=74844966
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023549866A Pending JP2024507810A (ja) | 2021-02-18 | 2022-02-18 | 高脂血症又は混合型脂質異常症に罹患しているスタチン不耐性患者における使用のためのオビセトラピブ及びエゼチミブの併用療法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240189311A1 (https=) |
| EP (1) | EP4294387A1 (https=) |
| JP (1) | JP2024507810A (https=) |
| KR (1) | KR20230159380A (https=) |
| CN (1) | CN117042770A (https=) |
| AU (1) | AU2022223224A1 (https=) |
| BR (1) | BR112023016682A2 (https=) |
| CA (1) | CA3210033A1 (https=) |
| IL (1) | IL304544A (https=) |
| MX (1) | MX2023009613A (https=) |
| WO (1) | WO2022177428A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12006305B2 (en) | 2022-07-05 | 2024-06-11 | Newamsterdam Pharma B.V. | Salts of obicetrapib and processes for their manufacture and intermediates thereof |
| WO2024165395A1 (en) * | 2023-02-07 | 2024-08-15 | Newamsterdam Pharma B.V. | Obicetrapib and ezetimibe combination treatment and fixed dose pharmaceutical compositions |
| WO2025146445A1 (en) * | 2024-01-03 | 2025-07-10 | Newamsterdam Pharma B.V. | Pharmaceutical compositions of obicetrapib and ezetimibe |
| WO2025146262A1 (en) * | 2024-01-03 | 2025-07-10 | Newamsterdam Pharma B.V. | Obicetrapib for use in the treatment of hemoglobinopathies |
| WO2025146446A1 (en) * | 2024-01-03 | 2025-07-10 | Newamsterdam Pharma B.V. | Pharmaceutical compositions of obicetrapib |
| WO2025147235A1 (en) * | 2024-01-03 | 2025-07-10 | Newamsterdam Pharma B.V. | Fixed dose combination composition of obicetrapib and ezetimibe |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA90269C2 (ru) * | 2004-04-02 | 2010-04-26 | Мицубиси Танабе Фарма Корпорейшн | Тетрагидрохинолиновые производные и способ их получения |
| MX369471B (es) * | 2014-02-05 | 2019-11-08 | Dezima Pharma B V | Inhibidor de proteina de transferencia del ester de colesterilo (cetp) y composiciones farmaceuticas que comprenden el inhibidor para uso en el tratamiento o prevencion de enfermedades cardiovasculares. |
| WO2017023166A1 (en) * | 2015-08-04 | 2017-02-09 | Dezima Pharma B.V. | Pharmaceutical composition and therapeutic combination comprising a cholesteryl ester transfer protein inhibitor and a cholesterol absorption inhibitor |
| US12006305B2 (en) * | 2022-07-05 | 2024-06-11 | Newamsterdam Pharma B.V. | Salts of obicetrapib and processes for their manufacture and intermediates thereof |
| JP2025527686A (ja) * | 2022-08-22 | 2025-08-22 | ニューアムステルダム・ファルマ・ベー・フェー | オビセトラピブ及びエゼチミブ併用治療及び固定用量医薬組成物 |
-
2022
- 2022-02-18 CN CN202280015230.8A patent/CN117042770A/zh active Pending
- 2022-02-18 JP JP2023549866A patent/JP2024507810A/ja active Pending
- 2022-02-18 AU AU2022223224A patent/AU2022223224A1/en active Pending
- 2022-02-18 KR KR1020237028087A patent/KR20230159380A/ko active Pending
- 2022-02-18 CA CA3210033A patent/CA3210033A1/en active Pending
- 2022-02-18 MX MX2023009613A patent/MX2023009613A/es unknown
- 2022-02-18 BR BR112023016682A patent/BR112023016682A2/pt unknown
- 2022-02-18 EP EP22705485.5A patent/EP4294387A1/en active Pending
- 2022-02-18 US US18/277,851 patent/US20240189311A1/en active Pending
- 2022-02-18 WO PCT/NL2022/050083 patent/WO2022177428A1/en not_active Ceased
-
2023
- 2023-07-18 IL IL304544A patent/IL304544A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024507810A5 (https=) | ||
| JP7660600B2 (ja) | 慢性炎症性疾患および／または自己免疫疾患の予防または治療における使用のためのビドフルジムス（Ｖｉｄｏｆｌｕｄｉｍｕｓ）の投与レジメン | |
| JP2022177142A5 (https=) | ||
| CN1440283A (zh) | 有机化合物的联合形式 | |
| JPH06502854A (ja) | 老年痴呆、過食症、片頭痛または食欲不振の治療用のパロキセチンの使用 | |
| BG102669A (bg) | Метод за лечение и фармацевтичен състав | |
| JP2006513184A5 (https=) | ||
| JP2022554276A5 (https=) | ||
| JP2024531188A5 (https=) | ||
| JP2024527023A5 (https=) | ||
| MX2024010637A (es) | Nuevas combinaciones terapeuticas para el tratamiento de enfermedades pulmonares intersticiales fibrosantes progresivas. | |
| JP2023538522A5 (https=) | ||
| IL310115A (en) | Treatment of his hyporesponders | |
| JP2025508359A5 (https=) | ||
| RU2008119454A (ru) | Лекарственное средство для защиты моторного нейрона у пациентов с боковым амиотрофическим склерозом | |
| JP2023549849A5 (https=) | ||
| JP2022177119A5 (https=) | ||
| JPH06503806A (ja) | 胃腸疾病を処置するための５―ジフルオロメトキシ―２―［（３，４―ジメトキシ―２―ピリジル）メチルスルフィニル］ベンズイミダゾール及び抗ヘリコバクター剤含有医薬組成物 | |
| JP2023526418A5 (https=) | ||
| JP2021530568A5 (https=) | ||
| CA2368352A1 (en) | Method for treating neurodegeneration | |
| JP2025522146A5 (https=) | ||
| CA2480275A1 (en) | Statin therapy for enhancing cognitive maintenance | |
| JP2025511402A5 (https=) | ||
| JP2005525391A5 (https=) |